Rare Disease Week, the FDA, mortality in autism, trajectories and subcategories

This week’s podcast summarizes some highlights in scientific research and includes a recognition of Rare Disease Week and actions taken by the FDA to ease the criteria for evaluating genetic therapies for rare genetic disorders, the best study to date on the mortality in autism, genetic prediction of outcome in individuals with a diagnosis, and …

Continue reading "Rare Disease Week, the FDA, mortality in autism, trajectories and subcategories"